TAVOLIMAB
UNII 4LU9B48U4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Tavolimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4LU9B48U4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1635395-25-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4LU9B48U4D

CAS Registry Number

1635395-25-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAVOLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C120041

National Cancer Institute reference terminology for clinical and research data.

INN ID

10420

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-168

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tavolimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TAVOLIMAB

TAVOLIXIZUMAB

Common Names & Synonyms

HUMAN IGG1 KAPPA ANTI-HUMAN OX40 MONOCLONAL ANTIBODY MEDI0562

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSTNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, OX40, CD134)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-451) (CHIMERIC VH (MUS MUSCULUS IGHV3-8*02 -(IGHD)-HOMO SAPIENS IGHJ4*01) (8.7.15) (1- 121) -HOMO SAPIENS IGHG1*03, G1M3 (CH1 (122-219), HINGE (220-234), CH2 (235-344), CH3 (345-449), CHS (450-451)) (122-451)), (224-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (88.40%) -IGKJ1*01) (6.3.9) (1'-107') -HOMO SAPIENS IGKC*01, KM3 (108'-214')) DIMER (230-230'':233-233'')-BISDISULFIDE

TAVOLIMAB [INN]

TAVOLIMAB [USAN]

TAVOLIMAB [WHO-DD]